Insulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells. The role of DDAH

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages

  Eid, Hilde Marie Angell ^a   Lyberg, Torstein ^a   Arnesen, Harald ^a   Seljeflot, Ingebjørg ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adiponectin; ADMA; DDAH; Human cultured endothelial cells; Insulin

Indexed keywords

ADIPONECTIN; DIMETHYLARGININASE; INSULIN; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOACCUMULATION; CELL LINE; CELL LYSATE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADIPONECTIN; AMIDOHYDROLASES; ARGININE; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; INSULIN; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 34848863623     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.008     Document Type: Article

References (38)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 6423 (1993) 801-809
2. Kurowska E.M. Nitric oxide therapies in vascular diseases. Curr Pharm 8 3 (2002) 155-166
3. Boger R.H., Bode-Boger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 18 (1998) 1842-1847
4. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 8793 (1992) 572-575
5. Achan V., Broadhead M., Malaki M., et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23 8 (2003) 1455-1459
6. Fard A., Tuck C.H., Donis J.A., et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20 9 (2000) 2039-2044
7. Eid H.M., Eritsland J., Larsen J., Arnesen H., and Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis 166 2 (2003) 279-284
8. Stuhlinger M.C., Abbasi F., Chu J.W., et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287 11 (2002) 1420-1426
9. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 12 (1988) 1595-1607
10. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88 6 (2003) 2399-2403
11. Steinberg H.O., and Baron A.D. Insulin-dependent diabetes mellitus and nitrovasodilation. Important and complex interactions. Circulation 95 3 (1997) 560-561
12. Wohlin M., Sundstrom J., Arnlov J., et al. Impaired insulin sensitivity is an independent predictor of common carotid intima-media thickness in a population sample of elderly men. Atherosclerosis 170 1 (2003) 181-185
13. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 1 (1999) 79-83
14. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 6 (2000) 1595-1599
15. Lin K.Y., Ito A., Asagami T., et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106 8 (2002) 987-992
16. Eid H.M., Arnesen H., Hjerkinn E.M., Lyberg T., and Seljeflot I. Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 53 12 (2004) 1574-1579
17. Eid H.M.A., Reims H., Arnesen H., et al. Decreased levels of asymmetric dimethylarginine (ADMA) during acute hyperinsulinemia. Atherosclerosis Suppl (2006) 357
18. Ito A., Tsao P.S., Adimoolam S., et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 24 (1999) 3092-3095
19. Myers P.R., Parker J.L., Tanner M.A., and Adams H.R. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium. Shock 1 1 (1994) 73-78
20. De Keulenaer G.W., Alexander R.W., Ushio-Fukai M., Ishizaka N., and Griendling K.K. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329 Pt 3 (1998) 653-657
21. McVeigh G.E., Brennan G.M., Johnston G.D., et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 8 (1992) 771-776
22. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., and Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27 3 (1996) 567-574
23. Chan N.N., Vallance P., and Colhoun H.M. Nitric oxide and vascular responses in type I diabetes. Diabetologia 43 2 (2000) 137-147
24. De Vriese A.S., Verbeuren T.J., Van d V., Lameire N.H., and Vanhoutte P.M. Endothelial dysfunction in diabetes. Br J Pharmacol 130 5 (2000) 963-974
25. Ito A., Egashira K., Narishige T., Muramatsu K., and Takeshita A. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus. Circ J 66 9 (2002) 811-815
26. Lin K.Y., Ito A., Asagami T., et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106 8 (2002) 987-992
27. Sorrenti V., Mazza F., Campisi A., et al. High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Curr Neurovasc Res 3 1 (2006) 49-54
28. Dimmeler S., Fleming I., Fisslthaler B., et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 6736 (1999) 601-605
29. Hermann C., Assmus B., Urbich C., Zeiher A.M., and Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20 2 (2000) 402-409
30. Aspelin T., Kiil S., and Lyberg T. Limited value of serum NOx measurement for monitoring endogenous nitric oxide (NO) production. Thromb Haemost Suppl (2001) 452
31. Montagnani M., Ravichandran L.V., Chen H., Esposito D.L., and Quon M.J. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 16 8 (2002) 1931-1942
32. Ozaki M., Kawashima S., Hirase T., et al. Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am J Pathol 160 4 (2002) 1335-1344
33. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278 11 (2003) 9073-9085
34. Tan K.C., Xu A., Chow W.S., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89 2 (2004) 765-769
35. Shimabukuro M., Higa N., Asahi T., et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88 7 (2003) 3236-3240
36. Kawanami D., Maemura K., Takeda N., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314 2 (2004) 415-419
37. Chen H., Montagnani M., Funahashi T., Shimomura I., and Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278 45 (2003) 45021-45026
38. Hattori Y., Suzuki M., Hattori S., and Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 46 11 (2003) 1543-1549